|
|
||||||||
Ann Thorac Surg 1995;60:1406-1409
© 1995 The Society of Thoracic Surgeons
Department of Cardiothoracic Surgery, Cedars-Sinai Medical Center, Los Angeles, California, USA
Accepted for publication April 28, 1995.
* Address reprint requests to Dr Blanche, Heart Transplant Program, Cedars-Sinai Medical Center, 8700 Beverly Blvd, Suite 6215, Los Angeles, CA 90048.
We present 2 patients who underwent orthotopic heart transplantation for end-stage Chagas' cardiomyopathy. Despite immunosuppressive therapy, postoperative prophylaxis with nifurtimox appeared to prevent Trypanosoma cruzi reactivation. Neither patient has shown signs of Chagas' myocarditis, and both are clinically well 12 and 72 months after transplantation. The successful outcome of our patients suggests that heart transplantation is a reasonable therapeutic option in patients with end-stage Chagas' cardiomyopathy.
This article has been cited by other articles:
![]() |
D. R. Snydman, M. Walker, and J. R. Zunt Parasitic Central Nervous System Infections in Immunocompromised Hosts Clinical Infectious Diseases, April 1, 2005; 40(7): 1005 - 1015. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Arribas, D. A. Pascual, F. Gutierrez, V. Ray, J. Garcia-Puente, M. Valdes, and R. Arcas Successful biventricular assistance after heart transplantation Ann. Thorac. Surg., February 1, 2004; 77(2): 720 - 721. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Albes, F. S. Eckstein, M. K. Heinemann, and G. Ziemer Successful weaning of a transplanted heart from biventricular assist device Ann. Thorac. Surg., July 1, 2000; 70(1): 277 - 278. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Kierszenbaum Chagas' Disease and the Autoimmunity Hypothesis Clin. Microbiol. Rev., April 1, 1999; 12(2): 210 - 223. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |